Single-Cell Omics Market

Table of Content

1. PREFACE
1.1. Market Overview
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations

2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates

3.2.2. Currency Coverage and Foreign Exchange Rate
3.2.2.1. Major Currencies Affecting the Market
3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
3.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
3.2.2.4. Strategies for Mitigating Foreign Exchange Risk

3.2.3. Trade Policies
3.2.3.1. Impact of Trade Barriers on the Market
3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers

3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Single-Cell Omics
6.3. History and Evolution of Single-Cell Omics
6.4. Applications of Single-Cell Omics
6.5. Challenges Associated with Single-Cell Omics
6.6. Future Perspectives

7. COMPETITIVE LANDSCAPE
7.1. Chapter Overview
7.2. Single-Cell Omics Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Type of Company

7.2.5. Single-Cell Omics Market: Overall Market Landscape
7.2.5.1. Analysis by Type of Product
7.2.5.2. Analysis by Type of Technology
7.2.5.3. Analysis by Therapeutic Area
7.2.5.4. Analysis by Application
7.2.5.5. Analysis by End User

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodologies

8.4. Company Competitiveness Analysis: Single-Cell Omics
8.4.1. Single-Cell Omics Companies Based in North America (Peer Group 1)
8.4.2. Single-Cell Omics Companies Based in Europe (Peer Group 2)
8.4.3. Single-Cell Omics Companies Based in Asia-Pacific (Peer Group 3)
8.4.4. Single-Cell Omics Companies Based in Middle East and North Africa, and Latin America (Peer Group 4)

8.5. Key Findings

9. COMPANY PROFILES
9.1. Chapter Overview
9.2. Becton, Dickinson, and Company
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Service / Product Portfolio
9.2.4. Recent Developments and Future Outlook

* Similar detail is presented for other below mentioned companies based on information in the public domain

9.3. 10x Genomics
9.4. ANGLE
9.5. Bio-Rad Laboratories
9.6. CELLENION
9.7. Lumiprobe
9.8. CYTENA
9.9. Danaher
9.10. Illumina
9.11. Mission Bio
9.12. PerkinElmer
9.13. Roche
9.14. Standard BioTools

10. MERGERS AND ACQUISITIONS
10.1. Chapter Overview
10.2. Type of Mergers and Acquisitions

10.3. Mergers and Acquisitions: Single-Cell Omics Providers
10.3.1. Analysis by Year of Agreement
10.3.2. Analysis by Type of Agreement

10.3.3. Analysis by Geography
10.3.3.1. Intracontinental and Intercontinental Agreements
10.3.3.2. International and Local Agreements

10.4. Most Active Players: Analysis by Number of Agreements

11. PATENT ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology

11.3. Single-Cell Omics: Patent Analysis
11.3.1. Analysis by Patent Publication Year
11.3.2. Analysis by Patent Application Year
11.3.3. Analysis by Granted Patents and Patent Applications
11.3.4. Analysis by Patent Jurisdiction
11.3.5. Analysis by CPC Symbols
11.3.6. Analysis by Type of Applicant
11.3.7. Leading Industry Players: Analysis by Number of Patents
11.3.8. Leading Non-Industry Players: Analysis by Number of Patents
11.3.9. Leading Patent Assignees: Analysis by Number of Patents

11.3.10. Patent Benchmarking Analysis
11.3.10.1. Analysis by Patent Characteristics

11.3.11. Patent Valuation
11.3.12. Leading Patents by Number of Citations

12. PORTER’S FIVE FORCES ANALYSIS

13. CASE STUDY: NEXT GENERATION SEQUENCING SERVICE PROVIDERS LANDSCAPE

14. MARKET IMPACT ANALYSIS
14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion

15. GLOBAL SINGLE-CELL OMICS MARKET
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Trends Disruption Impacting Market
15.4. Global Single-Cell Omics Market: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

15.5. Multivariate Scenario Analysis
15.5.1. Conservative Scenario
15.5.2. Optimistic Scenario

15.6. Key Market Segmentations

16. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix

16.6. Single-Cell Omics Market by Type of Product: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.1 Single-Cell Omics Market for Instruments: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
16.6.2. Single-Cell Omics Market for Consumables: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

17. MARKET OPPORTUNITIES BASED ON TECHNOLOGY
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix

17.6. Single-Cell Omics Market by Technology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.6.1. Single-Cell Omics Market for Single-Cell Proteomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.6.2. Single-Cell Omics Market for Single-Cell Metabolomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.6.3. Single-Cell Omics Market for Single-Cell Transcriptomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
17.6.4. Single-Cell Omics Market for Single-Cell Genomics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

18. MARKET OPPORTUNITIES BASED ON THERAPEUTIC AREA
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix

18.6. Single-Cell Omics Market by Therapeutic Area: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.1. Single-Cell Omics Market for Immunology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.2. Single-Cell Omics Market for Neurology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.3. Single-Cell Omics Market for Oncology: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
18.6.4. Single-Cell Omics Market for Others: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

19. MARKET OPPORTUNITIES BASED ON TYPE OF APPLICATION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix

19.6. Single-Cell Omics Market by Type of Application: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.1. Single-Cell Omics Market for Diagnostics: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.2. Single-Cell Omics Market for Research: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
19.6.3. Single-Cell Omics Market for Other Applications: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

20. MARKET OPPORTUNITIES BASED ON END USER
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix

20.6. Single-Cell Omics Market by End User: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.1. Single-Cell Omics Market for Pharmaceutical and Biotechnology Companies: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.2. Single-Cell Omics Market for Academic Institutes and Research Organizations: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.3. Single-Cell Omics Market for Hospitals and Diagnostic Laboratories: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
20.6.4. Single-Cell Omics Market for Other End Users: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

21. MARKET OPPORTUNITIES FOR SINGLE-CELL OMICS IN NORTH AMERICA
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. Single-Cell Omics Market in North America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.1. Single-Cell Omics Market in the US: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.2. Single-Cell Omics Market in Canada: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
21.6.3. Single-Cell Omics Market in Mexico: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR SINGLE-CELL OMICS IN EUROPE
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. Single-Cell Omics Market in Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.1. Single-Cell Omics Market in Germany: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.2. Single-Cell Omics Market in France: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.3. Single-Cell Omics Market in Italy: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.4. Single-Cell Omics Market in Spain: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.5. Single-Cell Omics Market in the UK: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
22.6.6. Single-Cell Omics Market in Rest of Europe: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. MARKET OPPORTUNITIES FOR HOME HEALTHCARE IN ASIA-PACIFIC
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix

23.6. Home Healthcare Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.1. Home Healthcare Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.2. Home Healthcare Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.3. Home Healthcare Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.4. Home Healthcare Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.5. Home Healthcare Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.7. Data Triangulation and Validation

24. MARKET OPPORTUNITIES FOR HOME HEALTHCARE IN MIDDLE EAST AND NORTH AFRICA (MENA)
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix

24.6. Home Healthcare Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.1. Home Healthcare Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 205)
24.6.2. Home Healthcare Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
24.6.3. Home Healthcare Market in United Arab Emirates (UAE): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

24.7. Data Triangulation and Validation

25. MARKET OPPORTUNITIES FOR SINGLE-CELL OMICS IN LATIN AMERICA
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Revenue Shift Analysis
25.4. Market Movement Analysis
25.5. Penetration-Growth (P-G) Matrix

25.6. Single-Cell Omics Market in Latin America: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
25.6.1. Single-Cell Omics Market in Argentina: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)
25.6.2. Single-Cell Omics Market in Brazil: Historical Trends (Since 2019) and Forecasted Estimates (Till 2035)

25.7. Data Triangulation and Validation

26. APPENDIX 1: TABULATED DATA

27. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

28. CUSTOMIZATION OPPORTUNITIES

29. ROOTS SUBSCRIPTION SERVICES

30. AUTHOR DETAIL